Mark For: CETOSOMES® trademark registration is intended to cover the categories of
Website | www.cymbiotics.net |
Research | OneLook Acronym Finder |
Serial Number | 88388677 |
Registration Number | 6056485 |
Mark Literal Elements | CETOSOMES |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK |
Register | PRINCIPAL |
Current Location | PUBLICATION AND ISSUE SECTION 2020-05-19 |
Basis | 1(a) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | Yes |
Current Use | Yes |
Intent To Use | No |
Filed ITU | No |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Law Office Assigned | L90 |
Employee Name | TARCU, CATHERINE L |
2015-07-21 | Date of First Use |
2018-11-01 | Date of Use In Commerce |
2019-04-16 | Application Filed |
2019-10-15 | Status: Live/Pending |
2019-11-01 | Location: TMEG LAW OFFICE 109 |
2019-11-01 | Transaction Date |
2020-03-03 | Published |
2020-05-19 | Location: PUBLICATION AND ISSUE SECTION |
2020-05-19 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
2020-05-19 | Trademark Registered |
2025-05-19 | Maintenance Early File Date |
2026-05-19 | Maintenance On Time Date |
2026-11-19 | Maintenance Late Fee Date |
Party: | Cymbiotics, Inc. |
Address | 135 St. James Drive Sonoma, CALIFORNIA UNITED STATES 95476 |
Legal Entity Type | Corporation |
Legal Entity State | NEVADA |
Drawing | 2019-04-16 | |
Specimen | 2019-04-16 | |
TEAS Plus New Application | 2019-04-16 | |
Offc Action Outgoing | 2019-06-25 | |
XSearch Search Summary | 2019-06-25 | |
Change of Address | 2019-10-14 | |
Response to Office Action | 2019-10-14 | |
Amendment and Mail Process Complete | 2019-10-16 | |
TRAM Snapshot of App at Pub for Oppostn | 2020-01-28 | |
Notice of Publication | 2020-02-12 | |
Notification Of Notice of Publication | 2020-02-12 | |
OG Publication Confirmation | 2020-03-03 | |
Registration Certificate | 2020-05-19 | |
Change Address or Representation Form | 2020-09-15 |
IC 005. US 006 018 044 046 051 052. G & S: Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for biological actives that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of nanoparticles that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders. FIRST USE: 20150721. FIRST USE IN COMMERCE: 20181101
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for biological actives that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of nanoparticles that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders |
GS0051 | Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for biological actives that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of nanoparticles that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders |
Description | Date | Proceeding Number |
---|---|---|
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2020-09-15 | |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2020-09-15 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2020-09-15 | |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2020-09-15 | |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2020-09-15 | 88888 |
REGISTERED-PRINCIPAL REGISTER | 2020-05-19 | |
PUBLISHED FOR OPPOSITION | 2020-03-03 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-03-03 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-02-12 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-01-27 | |
ASSIGNED TO EXAMINER | 2020-01-09 | 82093 |
ASSIGNED TO EXAMINER | 2019-11-01 | 88577 |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-10-15 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-10-14 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2019-10-14 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-10-14 | 88889 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-06-25 | 6325 |
NON-FINAL ACTION WRITTEN | 2019-06-25 | 68181 |
NON-FINAL ACTION E-MAILED | 2019-06-25 | 6325 |
ASSIGNED TO EXAMINER | 2019-06-25 | 68181 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-05-03 | |
NEW APPLICATION ENTERED IN TRAM | 2019-04-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.